News Summary: Baxter to buy Gambro in $2.76B deal

News Summary: Baxter Int'l to buy Swedish dialysis product maker Gambro in $2.76 billion deal

Associated Press

THE DEAL: Drug and medical device maker Baxter International Inc. said Tuesday it plans to buy the privately held Swedish company Gambro AB for about $2.76 billion. The deal is worth about $4 billion, counting debt.

THE REASONING: Baxter wants to broader its dialysis product portfolio. Dialysis involves removing blood from a patient, running it through a machine that cleans out impurities and then returning it to the patient's body.

ABOUT BAXTER: Based in Deerfield, Ill., Baxter also makes vaccines, bleeding disorder treatments and intravenous administration sets to deliver medicines and fluids to patients.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You